SMS Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 01, 2025.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of SMS Pharmaceuticals, at its meeting on July 1, 2025, approved the re-appointment of Mr. Vamsi Krishna Potluri as Whole Time Director (designated as Executive Director) for a further period of three years, from July 1, 2025 to June 30, 2028. The re-appointment is subject to shareholder approval at the next general meeting. Mr. Potluri holds a Bachelor's in Electrical and Electronics Engineering from BITS Pilani, Dubai, and a Master's in Engineering Management from Missouri University of Science and Technology, USA. He has been with SMS Pharmaceuticals since 2014 and also leads the marketing division and R&D operations. He is the eldest son of the Chairman and Managing Director, Mr. Ramesh Babu Potluri, and brother of Non-Executive Director Mr. Trilok Potluri.
This is a routine re-appointment of an existing promoter-family director, so no material impact on shareholders is expected. The continuity in leadership at the board level may be viewed as a stability signal, though the re-appointment still requires shareholder approval.